Loading...

A GLOBAL COMPANY INTEGRATED IN THE ANIMAL AND HUMAN HEALTH INDUSTRIES WITH A DIVERSIFIED PORTFOLIO OF PRODUCTS AND BUSINESSES AND A BROAD CLIENT BASE OF TOP-TIER CUSTOMERS WITH WHOM IT HAS A LONG-LASTING TRUSTED RELATIONSHIP.

Labaiana map
Equity Story February 2026 Labiana
Portada Informe integrado 2025 Labiana EN

OTHER RELEVANT INFORMATION

24/04/2026 13:02 LABIANA Other Relevant Information: The Company hereby publishes a free translation of the publication issued on 24 April 2025 making public the details and reasons for the qualification contained in the auditor’s report corresponding to the consolidated financial statements of LABIANA HEALTH. S. A. and SUBSIDIARIES for the year ended 31 December 2025. View pdf. (135 KB)

22/04/2026 17:53 LABIANA Other Relevant Information: Labiana hereby publishes a free translation of the publication issued on April 21, 2025, announcing the publication of its audited annual financial statements. View pdf. (14 MB)

17/04/2026 18:19 LABIANA Other Relevant Information: LABIANA announces that it will release its financial results for the 2025 fiscal year on Tuesday, April 21, 2026, followed by a webcast to present the results via videoconference on the same day, April 21, at 11:00 a.m. Ver pdf (85 KB)

01/04/2026 11:29 LABIANA Other Relevant Information: LABIANA announces the sale of treasury shares as part of the Company’s capital increase announced on March 19. View pdf (88 KB)

 

———- View more ———-

12/12/2025 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports on the details of the communication received regarding the communication that ORTEGA FARMING, S.L.U. has submitted to the National Securities Market Commission, modifying the communication that was published by the Company through the corresponding Other Relevant Information dated December 5, 2025. See pdf. (123 KB)

12/12/2025 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports on the details of the sales transactions of LABIANA shares carried out by BLUECOLT, S.A., represented by Mr. Manuel Ramos Ortega, Chief Executive Officer of LABIANA, on December 10, 2025. See pdf. (142 KB)

05/12/2025 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports on the details of the sales transactions of LABIANA shares carried out by ORTEGA FARMING S.L.U., represented by Mr. Manuel Ramos Ortega, Chief Executive Officer of LABIANA, on December 3, 2025. See pdf. (147 KB)

18/11/2025 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports on the details of the sales transactions of LABIANA shares carried out by ORTEGA FARMING S.L.U., represented by Mr. Manuel Ramos Ortega, Chief Executive Officer of LABIANA, on November July 14, 2025. See pdf (143 KB)

———- View more ———-

On December 27, 2024, LABIANA Other Relevant Information: Operations carried out by executives. LABIANA reports the details of the share sale operations of LABIANA carried out by ORTEGA FARMING S.L.U., represented by Mr. Manuel Ramos Ortega, CEO of LABIANA, on December 27, 2024. View pdf (148 KB)

On December 27, 2024, LABIANA Other Relevant Information: Other relevant information. LABIANA reports on the agreement to enter the capital of the Family Office ANCESMEI. View pdf (52 KB)

On December 24, 2024, LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA reports the details of the share sale operations of LABIANA carried out by Ignacio Yáñez Minondo, a member of LABIANA’s Board of Directors, between December 20, 2024, and December 23, 2024. View pdf (148 KB)

17/12/2024 LABIANA Other Relevant Information: Transactions carried out by executives. LABIANA reports the details of the share sales transactions of LABIANA carried out by Antonio José Ortiz Romera, Commercial Director of Animal Health at LABIANA, on December 11, 2024. View pdf (147 KB)

———- View more ———-

22/12/2023 LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA communicates the details of the share buyback transactions carried out by the Company between December 21, 2023, and December 22, 2023, in execution of the Share Buyback Program approved by the Board of Directors in the session of September 25, 2023. Ver pdf (135 KB)

22/12/2023 LABIANA Other Relevant Information: Other relevant information. The Company reports the agreements adopted at the Extraordinary General Shareholders’ Meeting held on December 22, 2023.. Ver pdf (235 KB)

19/12/2023 LABIANA Other Relevant Information: Share buyback programs, stabilization, and treasury stock. LABIANA reports the details of the share buyback transactions carried out by the Company on December 15, 2023, in execution of the Share Buyback Program approved by the Board of Directors in the session of September 25, 2023. Ver pdf (132 KB)

23/11/2023 LABIANA Other Relevant Information: Call for a Meeting or Assembly. According to the OIR published by LABIANA on November 22, 2023, the company announced that by agreement of the Board of Directors of LABIANA, the shareholders are summoned to the Extraordinary General Meeting of Shareholders, to be held on December 22, 2023. Ver pdf (183 KB)

———- Ver más ———-

31/10/2022 LABIANA OTHER RELEVANT INFORMATION: Information on forecasts published on October 28, 2022. Ver pdf (140 KB)

31/10/2022 LABIANA OTHER RELEVANT INFORMATION: Labiana announces the launch of a new veterinary medicine. Ver pdf (344 KB)

28/10/2022 LABIANA OTHER RELEVANT INFORMATION: Communication of future update of comparative figures for 2021 in the profit and loss account. Ver pdf (104 KB)

28/10/2022 LABIANA OTHER RELEVANT INFORMATION: Semiannual financial and audit/review reports. Financial information for the first half of 2022. Ver pdf (17 MB)

———- Ver más ———-

INVESTOR RELATIONS

    LABIANA LIFE SCIENCES, SAU como responsable del tratamiento tratará tus datos con la finalidad de dar respuesta a tu consulta o petición. Puedes acceder, rectificar y suprimir tus datos, así como ejercer otros derechos consultando la información adicional y detallada sobre protección de datos en nuestra Política de privacidad

    He leído y acepto las condiciones contenidas en la política de privacidad sobre el tratamiento de mis datos para gestionar mi consulta o petición.

    Enviarte información comercial sobre los productos, servicios, novedades de LABIANA LIFE SCIENCES, SAU

    LABIANA HEALTH, S.A.
    TIN A87992616
    Avenida Europa, 34 1ºD
    28023 Pozuelo de Alarcón (Madrid)
    LABIANA HEALTH, S.A.
    Email: investors@labiana.com
    Phone: (+34) 91 991 26 28
    Privacy overview

    This website uses cookies to offer you the best possible user experience. Cookies’ information is stored in your browser and performs functions such as recognizing when you return to our website or helping our team to understand which sections of the website you find most interesting and useful. More information in the privacy policy and cookie policy!